The use of mineralocorticoid receptor antagonists in the treatment of heart failure: a literature review
Mineralocorticoid receptor antagonists (MRAs) have proven to be highly effective therapeutic options in the treatment of patients with heart failure with reduced ejection fraction (HFrEF) based on randomized clinical trials. Current evidence in these patients clearly indicates that MRAs reduce morbi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Promenade Kft
2024-08-01
|
| Series: | Cardiologia Hungarica |
| Subjects: | |
| Online Access: | https://cardiologia.hungarica.eu/archive/2024-issues/2024-4-contents/the-use-of-mineralocorticoid-receptor-antagonists-in-the-treatment-of-heart-failure-a-literature-review?article=open |